• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPECT/CT 成像对 90Y 放射性栓塞后结直肠癌肝转移反应的预测价值。

The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.

机构信息

Interventional Radiology Department of Military Institute of Medicine, Warsaw, Poland.

Nuclear Medicine Department of Military Institute of Medicine, Warsaw, Poland.

出版信息

PLoS One. 2018 Jul 10;13(7):e0200488. doi: 10.1371/journal.pone.0200488. eCollection 2018.

DOI:10.1371/journal.pone.0200488
PMID:29990342
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6039046/
Abstract

The mT/N1 ratio, PAD, and AAD can be used as predictors of tumor response to SIRT treatment, and SPECT/CT imaging can be used for dosimetric assessment of radioembolization.

摘要

mT/N1 比值、PAD 和 AAD 可作为肿瘤对 SIRT 治疗反应的预测因子,SPECT/CT 成像可用于放射性栓塞的剂量评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/d1df789bdaf3/pone.0200488.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/8c83197e598d/pone.0200488.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/b7c4189d3a24/pone.0200488.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/d5025e0bebf8/pone.0200488.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/7d4c23a28238/pone.0200488.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/d1df789bdaf3/pone.0200488.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/8c83197e598d/pone.0200488.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/b7c4189d3a24/pone.0200488.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/d5025e0bebf8/pone.0200488.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/7d4c23a28238/pone.0200488.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06ea/6039046/d1df789bdaf3/pone.0200488.g005.jpg

相似文献

1
The Predictive Value of SPECT/CT imaging in colorectal liver metastases response after 90Y-radioembolization.SPECT/CT 成像对 90Y 放射性栓塞后结直肠癌肝转移反应的预测价值。
PLoS One. 2018 Jul 10;13(7):e0200488. doi: 10.1371/journal.pone.0200488. eCollection 2018.
2
Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.治疗前扩散加权磁共振成像对接受90Y微球放射性栓塞治疗的结直肠癌肝转移患者预后预测的价值
J Cancer Res Clin Oncol. 2017 Aug;143(8):1531-1541. doi: 10.1007/s00432-017-2395-5. Epub 2017 Mar 19.
3
Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin-99mTc-sulfur colloid SPECT.基于 99mTc-聚合白蛋白-99mTc-硫胶体 SPECT 融合的 90Y 放射性栓塞治疗剂量预测效用。
J Nucl Med. 2013 Dec;54(12):2055-61. doi: 10.2967/jnumed.113.123257. Epub 2013 Oct 21.
4
Systematic evaluation of tumoral 99mTc-MAA uptake using SPECT and SPECT/CT in 502 patients before 90Y radioembolization.在502例患者接受90Y放射性栓塞治疗前,使用单光子发射计算机断层扫描(SPECT)和SPECT/CT对肿瘤99mTc-大颗粒聚合白蛋白摄取情况进行系统评估。
J Nucl Med. 2015 Mar;56(3):333-8. doi: 10.2967/jnumed.114.150565. Epub 2015 Feb 5.
5
Insights into the Dose-Response Relationship of Radioembolization with Resin 90Y-Microspheres: A Prospective Cohort Study in Patients with Colorectal Cancer Liver Metastases.树脂90Y微球放射性栓塞剂量反应关系的见解:一项针对结直肠癌肝转移患者的前瞻性队列研究。
J Nucl Med. 2016 Jul;57(7):1014-9. doi: 10.2967/jnumed.115.166942. Epub 2016 Feb 23.
6
Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.99mTc-MAA单光子发射计算机断层扫描对90Y标记树脂微球在原发性和继发性肝肿瘤放射性栓塞中分布的预测价值
J Nucl Med. 2015 Nov;56(11):1654-60. doi: 10.2967/jnumed.115.162685. Epub 2015 Aug 27.
7
Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective 90Y radioembolization.基于动脉特异性 SPECT/CT 分区建模的个体化预测剂量学指导下的安全有效的 90Y 放射性栓塞治疗
J Nucl Med. 2012 Apr;53(4):559-66. doi: 10.2967/jnumed.111.097469. Epub 2012 Feb 17.
8
Partition Model-Based 99mTc-MAA SPECT/CT Predictive Dosimetry Compared with 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison.基于分割模型的 99mTc-MAA SPECT/CT 预测剂量与放射性栓塞治疗肝细胞癌后 90Y-TOF PET/CT 治疗剂量的定量一致性比较。
J Nucl Med. 2016 Nov;57(11):1672-1678. doi: 10.2967/jnumed.116.173104. Epub 2016 Jun 15.
9
90Y Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study.使用玻璃微球进行90Y放射性栓塞治疗结直肠癌肝转移:一项纳入531例患者的多中心研究的安全性和生存结果
J Nucl Med. 2016 May;57(5):665-71. doi: 10.2967/jnumed.115.166082. Epub 2015 Dec 3.
10
Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres.多模态成像可以预测不可切除的结直肠癌肝转移灶对钇-90标记树脂微球放射性栓塞治疗的代谢反应。
Phys Med Biol. 2008 Nov 21;53(22):6591-603. doi: 10.1088/0031-9155/53/22/019. Epub 2008 Oct 31.

引用本文的文献

1
PET/CT and SPECT/CT imaging of 90Y hepatic radioembolization at therapeutic and diagnostic activity levels: Anthropomorphic phantom study.90Y 放射性栓塞治疗和诊断活度水平的 PET/CT 和 SPECT/CT 成像:人体模型体模研究。
PLoS One. 2024 Feb 29;19(2):e0271711. doi: 10.1371/journal.pone.0271711. eCollection 2024.
2
Optimization of Y-90 Radioembolization Imaging for Post-Treatment Dosimetry on a Long Axial Field-of-View PET/CT Scanner.在长轴视野PET/CT扫描仪上优化Y-90放射性栓塞成像用于治疗后剂量测定
Diagnostics (Basel). 2023 Nov 9;13(22):3418. doi: 10.3390/diagnostics13223418.
3
A Theranostic Approach in SIRT: Value of Pre-Therapy Imaging in Treatment Planning.

本文引用的文献

1
First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.一线选择性体内放射治疗联合化疗与单纯化疗治疗结直肠癌肝转移患者的比较(FOXFIRE、SIRFLOX和FOXFIRE-全球研究):三项多中心、随机、3期试验的联合分析
Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3.
2
SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer.SIRFLOX:比较一线 mFOLFOX6(加或不加贝伐珠单抗)与 mFOLFOX6(加或不加贝伐珠单抗)加选择性内放射治疗转移性结直肠癌患者的随机 III 期试验。
J Clin Oncol. 2016 May 20;34(15):1723-31. doi: 10.1200/JCO.2015.66.1181. Epub 2016 Feb 22.
3
SIRT中的一种诊疗方法:治疗前成像在治疗规划中的价值。
J Clin Med. 2022 Dec 6;11(23):7245. doi: 10.3390/jcm11237245.
4
Yttrium-90 TOF-PET-Based EUD Predicts Response Post Liver Radioembolizations Using Recommended Manufacturer FDG Reconstruction Parameters.基于钇-90飞行时间正电子发射断层扫描的等效均匀剂量,使用推荐的制造商氟代脱氧葡萄糖重建参数预测肝脏放射性栓塞术后反应。
Front Oncol. 2021 Oct 5;11:592529. doi: 10.3389/fonc.2021.592529. eCollection 2021.
5
Evaluation of qualitative and quantitative data of Y-90 imaging in SPECT/CT and PET/CT phantom studies.Y-90 成像在 SPECT/CT 和 PET/CT 体模研究中的定性和定量数据的评估。
PLoS One. 2021 Feb 10;16(2):e0246848. doi: 10.1371/journal.pone.0246848. eCollection 2021.
6
Selective internal radiation therapy of hepatic tumors: Morphologic and functional imaging for voxel-based computer-aided dosimetry.肝脏肿瘤选择性内部放射治疗:基于体素的计算机辅助剂量学的形态学和功能成像。
Biomed Pharmacother. 2020 Dec;132:110865. doi: 10.1016/j.biopha.2020.110865. Epub 2020 Nov 3.
7
Regorafenib Prior to Selective Internal Radiation Therapy Using Y-Resin Microspheres for Refractory Metastatic Colorectal Cancer Liver Metastases: Analysis of Safety, Dosimetry, and Molecular Markers.在使用钇树脂微球进行选择性内放射治疗难治性转移性结直肠癌肝转移之前使用瑞戈非尼:安全性、剂量测定和分子标志物分析
Front Oncol. 2019 Jul 10;9:624. doi: 10.3389/fonc.2019.00624. eCollection 2019.
8
Quantitative Imaging Biomarkers for Y Distribution on Bremsstrahlung SPECT After Resin-Based Radioembolization.基于树脂的放射性栓塞后韧致辐射 SPECT 上 Y 分布的定量成像生物标志物。
J Nucl Med. 2019 Aug;60(8):1066-1072. doi: 10.2967/jnumed.118.219691. Epub 2019 Jan 17.
Tailoring 99mTc-Macroaggregated Albumin Administration to Optimize Patient Dose Reduction.
J Nucl Med Technol. 2015 Sep;43(3):220-1. doi: 10.2967/jnmt.114.151811. Epub 2015 Aug 13.
4
Fusion dual-tracer SPECT-based hepatic dosimetry predicts outcome after radioembolization for a wide range of tumour cell types.基于融合双示踪剂单光子发射计算机断层扫描的肝脏剂量测定可预测多种肿瘤细胞类型经放射性栓塞后的预后。
Eur J Nucl Med Mol Imaging. 2015 Jul;42(8):1192-201. doi: 10.1007/s00259-015-3048-z. Epub 2015 Apr 28.
5
Selective internal radiation therapy dosimetry.
Future Oncol. 2014 Nov;10(15 Suppl):77-81. doi: 10.2217/fon.14.230.
6
Liver Selective Internal Radiation Therapy with (90)Y resin microspheres: comparison between pre-treatment activity calculation methods.使用(90)Y树脂微球的肝脏选择性内放射治疗:治疗前活度计算方法的比较
Phys Med. 2014 Nov;30(7):752-64. doi: 10.1016/j.ejmp.2014.05.004. Epub 2014 Jun 9.
7
Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.214 例结直肠癌肝转移患者接受放射性栓塞治疗的 12 年经验:按时代和化疗分组的生存情况。
Eur J Nucl Med Mol Imaging. 2014 Oct;41(10):1861-9. doi: 10.1007/s00259-014-2799-2. Epub 2014 Jun 7.
8
Reply: A clinical dosimetric perspective uncovers new evidence and offers new insight in favor of 99mTc-macroaggregated albumin for predictive dosimetry in 90Y resin microsphere radioembolization.
J Nucl Med. 2013 Dec;54(12):2192-3. doi: 10.2967/jnumed.113.132852. Epub 2013 Nov 6.
9
99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization.99mTc-聚合白蛋白不能准确预测 90Y 树脂微球在肝动脉栓塞治疗中的肝内分布。
J Nucl Med. 2013 Aug;54(8):1294-301. doi: 10.2967/jnumed.112.117614. Epub 2013 Jun 7.
10
Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres.预测 90Y 放射性微球肝动脉栓塞治疗结直肠癌肝转移患者肿瘤内 99mTc-聚合白蛋白摄取的价值。
J Nucl Med. 2013 Apr;54(4):516-22. doi: 10.2967/jnumed.112.112508. Epub 2013 Feb 27.